semaglutide increased heart rate Resting drop from GLP-1 meds : r/Semaglutide Semaglutide cardiovascular outcomes align more

The STEP UP trial, a Phase 3b study published in The Lancet Diabetes & Endocrinology in 2025, evaluated a 7.2 mg weekly injection dose in over 1,400 adults with obesity (BMI of 30 or higher) and without diabetes

The probability of the risk of developing choroidal melanoma in patients with dysplastic nevi is comparable to the risk of developing cutaneous melanoma [29]

Conclusion Semaglutide is an effective and scientifically proven medication for managing type 2 diabetes and supporting weight loss

Science & studies 4.1 Key publications Pickart L

Lipoprotein(a) as a risk factor for cardiovascular diseases: pathophysiology and treatment perspectives

Work through them in order and focus on what you can actually act on right now